Navigation Links
Cure for common cold,,

The cure for the common cold remains as elusive as ever. A federal advisory committee recommended recently that the first drug aimed at treating the cause of the cold// rather than just its symptoms not be approved.

In a unanimous decision, the Food and Drug Administration’s advisory panel on anti-viral drugs said there were too many questions about the safety of the drug, which is made by ViroPharma Inc., to allow its widespread use merely to treat an ail-away by itself. The drug, known as Picovir, has attracted attention because it directly attacks a family of viruses, known as picornavirus, that cause half or more of the billion colds caught in the US each year. The drug lodges into a pocket in the virus’ coat, interfering with the germ’s ability to infect cells and make copies of itself. Other cold remedies merely suppress symptoms, like drying runny noses or coughs. In clinical trials, Picovir shortened the length of the cold to roughly six days from seven. Patients took the pills three times a day for five days. First treatment, however, has to start within 24 hours of onset of symptoms, which some panel members said might be difficult for a drug that would be sold by prescription. The major concern, was that Picovir appeared to lower the effectiveness of oral contraceptives, which might cause inadvertent pregnancies. Some women taking both Picovir and birth control pills experienced bleeding between their menstrual periods. The panel also questioned whether the drug could be used by the general population because the participants in the clinical trial were mainly young, white, otherwise healthy women.

'"/>




Page: 1

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Iron supplementation for a common side effect
3. E. coli strains resistant to a common antibiotic
4. Gastrointestinal ills more common in diabetics
5. Toxic effects common with AIDS treatments
6. Drooping eyelids more common in men
7. Unnatural death common in mentally ill
8. New Drug, Pleconaril speeds recovery from common cold
9. Relief from common back pain
10. Drugs control and industry departments to share a common e-platform
11. Periodontitis a common problem in patients with arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: